A joint webinar put on by Global Organization of EPA and DHA Omega 3s (GOED) and the United Natural Products Alliance (UNPA) will help companies understand the intentional adulteration provisions of FSMA.
Friday’s public meeting was an illuminating day of presentations, with multiple viewpoints and interests being aired. On the dietary supplements side, there were strong calls for companies to take the front door with the Agency.
Researchers in Israel reported that participants in a dieting study who showed greater Body Mass Index (BMI) decreases had higher potassium intakes than those with modest BMI decreases.
When it comes to legally marketing conventional food and dietary supplements with CBD and other cannabis-derived compounds, FDA and industry appear stuck in a catch-22.
Advocates are unanimous in saying that natural products could always benefit from more research. But what about when that research looks at disease endpoints?
Early returns from the FDA meeting on CBD regulation give a glimpse of the complexity of the regulatory questions, which might stretch the timeline for a new legal framework to extent beyond which many in the industry would find acceptable.
Frustration filled the air at the Dietary Supplements Regulatory Summit earlier this month when it became apparent that no progress has been made in the industry’s push for FDA to drop weight requirements on probiotic product labels.
“If we do not succeed in working together to reassure the card brands that they can safely support our industry, then we predict a significant decrease in CBD sales within the next few months,” the National Cannabis Industry Association (NCIA) has warned.
The main purpose of the Botanical Safety Consortium, a public-private effort bringing together stakeholders in the botanical supplements space, is “advancing the science of botanical safety evaluation, [and is] not involved in regulatory decisions or...
A new force is shaping the dietary supplement market, one that operates largely outside of normal industry channels. The growth of the online sales channel, and brands that operate exclusively in that space, is an increasingly powerful force.
A study published recently has found a level of liver toxicity for CBD, putting up a big caveat to the notion within the hemp/CBD world that its products have nothing in the way of safety concerns.
The time is now for industry to voluntarily improve the transparency of probiotic product quality, even in the absence of regulatory requirements, says a recent review.
Italy’s National Institute of Health reports a further six new hepatitis incidences linked to the consumption of turmeric-based food supplements bringing the total to ten cases.
It was a who’s who of the dietary supplement world in College Park for the FDA public meeting on responsible innovation in dietary supplements. Here are some of the key comments:
